After a journey of growth spanning 27 years as Cadila Healthcare Ltd. and the Zydus Group, we have evolved and transformed ourselves in response to the changing times.
Masters or Ph.D. in Biotechnology, Genomic Science, Biochemistry, Bioinformatics, Biomedical, Bioprocessing with a strong technical knowledge in the respective core domain and passion for life science-related industry segments.
Candidate should have experience in Oral formulations Solid and liquid for Handling of IPQA, APQR activity and Process Validation. Candidates must have experience in review of Analytical Document, Investigating out-of-specification results, and ensuring adherence to GMP guidelines.
M. Pharm Pharmaceutical Quality Assurance, Pharmaceutics, Industrial Pharmacy and Ph.D. in relevant discipline, preferably in Pharmaceutical Quality Assurance. fresh and experienced; good track record of publications, patents, grants
To create specialized content with supervision; support end-to-end publication, medical education content development process including documentation and approval in PromoMats, iEnvision; develop and maintain therapeutic area expertise; work in close collaboration with peers, team to develop best practices; and collaborate effectively with stakeholders.
Maintain awareness of current developments in own technology areas. Achieve and maintain consistent quality standards, Effective personal planning, and time management.
This is a non-supervisory position to support development of Reference materials. The successful applicant in this role will work on projects including Analytical Method Development for in process samples for synthetic lab.
Promote pharma product portfolio to healthcare professionals and institutions. Develop and maintain strong relationships with doctors, pharmacists, and key opinion leaders. Achieve sales targets and ensure market growth in the assigned territory.
Keep a daily log to document all activities completed each day. Perform duties in compliance with Company’s policies and procedures, including but not limited to those related to HIPAA and compliance.
Setting strategy for evaluating and implementing new technologies within the Analytical Development department, with a particular emphasis on state-of-the-art separation techniques